Latest Cash Flow News

IGO's December quarter report reveals robust performance at Greenbushes lithium mine but significant setbacks at Kwinana and Nova, culminating in a $79 million EBITDA loss and a strategic halt on Kwinana’s Plant 2.

Visionflex Group Limited reported a net cash outflow from operations for the December 2024 quarter but secured significant financing, extending its funding runway to nearly 15 quarters.

QPM Energy reported a 21.3% rise in electricity and gas sales revenue to $30.8 million in the December 2024 quarter, driven by strong electricity prices and strategic asset acquisition. The company also advanced its drilling program and optimized gas production despite a decline in third-party supply.

Appen's Q4 FY24 results reveal a robust 37% revenue increase excluding Google, alongside improved EBITDA profitability, driven by generative AI projects and strategic cost management.

Australian Strategic Materials (ASM) has secured a $5 million federal grant to accelerate its Dubbo Project, progressing rare earth recovery innovations while navigating a complex global market landscape.

Asset Vision Co Limited has reported a robust Q2 FY25, marked by significant revenue growth, improved cash flow, and effective cost management, positioning the company well for continued expansion.

OncoSil Medical has secured new distribution agreements across key international markets and achieved critical regulatory milestones, while raising $8 million to fuel its growth in pancreatic cancer treatment.

Mad Paws Holdings Limited reported a milestone positive cash EBITDA of $0.3 million in Q2 FY25, driven by strong marketplace growth and operational efficiencies. The company is amplifying its market presence with a $5.25 million brand campaign in partnership with Seven West Media.

Credit Corp Group Limited has announced a fully franked ordinary dividend of AUD 0.32 per share for the six months ending December 2024, signaling steady shareholder returns.

BlueBet Holdings has delivered positive EBITDA for the first half of FY25 ahead of schedule, driven by strategic customer reactivation and enhanced platform efficiencies following its merger with betr.

SciDev Ltd reports a seasonal revenue dip in Q2 FY25 due to US Oil & Gas sector uncertainty but marks a strategic milestone by securing its first PFAS treatment contracts in Europe.

Acrux Limited has launched its Nitroglycerin 0.4% Ointment and successfully raised nearly $4 million, positioning the specialty pharma company for sustained revenue growth.